These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 19957147

  • 41. Animal models of NASH: getting both pathology and metabolic context right.
    Larter CZ, Yeh MM.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1635-48. PubMed ID: 18752564
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Nov; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Diagnosis and therapy in NASH].
    Tokushige K.
    Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
    [Abstract] [Full Text] [Related]

  • 47. [Non-alcoholic steatohepatitis].
    Duvnjak M, Virović L.
    Acta Med Croatica; 2003 Sep; 57(3):189-99. PubMed ID: 14582465
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Imaging of NASH].
    Tanimoto A, Tomita K.
    Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice.
    Tajima K, Nakamura A, Shirakawa J, Togashi Y, Orime K, Sato K, Inoue H, Kaji M, Sakamoto E, Ito Y, Aoki K, Nagashima Y, Atsumi T, Terauchi Y.
    Am J Physiol Endocrinol Metab; 2013 Oct 15; 305(8):E987-98. PubMed ID: 23964070
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?
    Machado MV, Cortez-Pinto H.
    Expert Rev Gastroenterol Hepatol; 2011 Apr 15; 5(2):213-22. PubMed ID: 21476916
    [Abstract] [Full Text] [Related]

  • 57. Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis.
    Younossi ZM, Baranova A, Stepanova M, Page S, Calvert VS, Afendy A, Goodman Z, Chandhoke V, Liotta L, Petricoin E.
    J Proteome Res; 2010 Jun 04; 9(6):3218-24. PubMed ID: 20441224
    [Abstract] [Full Text] [Related]

  • 58. Is fatty liver always benign and should not consequently be treated?
    Fierbinteanu-Braticevici C, Negreanu L, Tarantino G.
    J Physiol Pharmacol; 2013 Feb 04; 64(1):3-9. PubMed ID: 23568965
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.